These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38589351)

  • 21. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
    Choudhury L; Rosen SD; Patel D; Nihoyannopoulos P; Camici PG
    Eur Heart J; 1997 Jan; 18(1):108-16. PubMed ID: 9049522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine.
    Maron BJ; Maron MS; Sherrid MV; Ommen SR; Rowin EJ
    Am J Cardiol; 2022 Nov; 183():150-152. PubMed ID: 36114018
    [No Abstract]   [Full Text] [Related]  

  • 24. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.
    Maron BJ; Maron MS; Wigle ED; Braunwald E
    J Am Coll Cardiol; 2009 Jul; 54(3):191-200. PubMed ID: 19589431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
    Taylor MR; Carniel E; Mestroni L
    Expert Rev Mol Diagn; 2004 Jan; 4(1):99-113. PubMed ID: 14711353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Acing" the Hidden Spade: Review of Diagnosis, Follow-up, Prognosis, and Various Associations of Apical Variant Hypertrophic Cardiomyopathy.
    Patel H; Ko Ko NL; Kumar S; Gros B
    Cureus; 2019 Jan; 11(1):e3979. PubMed ID: 30967979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a standard myectomy exist for obstructive hypertrophic cardiomyopathy? From the Morrow variations to precision surgery.
    Stefàno P; Argirò A; Bacchi B; Iannone L; Bertini A; Zampieri M; Cerillo A; Olivotto I
    Int J Cardiol; 2023 Jan; 371():278-286. PubMed ID: 36130619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress Cardiomyopathy in a Patient with Hypertrophic Cardiomyopathy: Case Presentation and Review of the Literature.
    Vinardell JM; Mihos CG; Nader A; Ro R; Escolar E; Santana O
    Rev Cardiovasc Med; 2018 Jun; 19(2):65-68. PubMed ID: 31032604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications.
    Wald DS; Law M; Morris JK
    Int J Cardiol; 2004 Dec; 97(3):479-84. PubMed ID: 15561336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apical hypertrophic nonobstructive cardiomyopathy in a pilot.
    Neutel JM; Myburgh DP
    Aviat Space Environ Med; 1987 Oct; 58(10):1005-8. PubMed ID: 3675461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?
    Bos JM; Ommen SR; Ackerman MJ
    Curr Opin Cardiol; 2007 May; 22(3):193-9. PubMed ID: 17413275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the robustness of network-based disease-gene prioritization methods reveals redundancy in the human interactome and functional diversity of disease-genes.
    Guney E; Oliva B
    PLoS One; 2014; 9(4):e94686. PubMed ID: 24733074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Towards integrative postmodern individualized medicine in terms of hierarchic emergence].
    Hou C
    Zhong Xi Yi Jie He Xue Bao; 2003 May; 1(1):5-8. PubMed ID: 15339600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?
    Ackerman MJ
    Curr Opin Cardiol; 2005 May; 20(3):175-81. PubMed ID: 15861004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Author Correction: Quantitative fragmentomics allow affinity mapping of interactomes.
    Gogl G; Zambo B; Kostmann C; Cousido-Siah A; Morlet B; Durbesson F; Negroni L; Eberling P; Jané P; Nominé Y; Zeke A; Østergaard S; Monsellier É; Vincentelli R; Travé G
    Nat Commun; 2022 Dec; 13(1):7555. PubMed ID: 36477203
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Demographic, Clinical, Biochemical, and Imaging Findings in Hypertrophic Cardiomyopathy Prognosis: A Network Meta-Analysis.
    Georgiopoulos G; Figliozzi S; Pateras K; Nicoli F; Bampatsias D; Beltrami M; Finocchiaro G; Chiribiri A; Masci PG; Olivotto I
    JACC Heart Fail; 2023 Jan; 11(1):30-41. PubMed ID: 36599547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features.
    Guo L; Ma Z; Yang W; Zhang F; Shao H; Liu L; Gao C; Tao L
    Glob Heart; 2023; 18(1):40. PubMed ID: 37547171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial bridging in hypertrophic cardiomyopathy: a plea for surgical correction.
    Fiorani B; Capuano F; Bilotta F; Guccione F; Santaniello E; Sinatra R; Alfieri O
    Ital Heart J; 2005 Nov; 6(11):922-4. PubMed ID: 16320929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical Research.
    Maron BJ; Rowin EJ; Ambe SP; Maron MS
    Am J Med; 2022 Oct; 135(10):1244-1246. PubMed ID: 35649468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine.
    Monda E; Bakalakos A; Rubino M; Verrillo F; Diana G; De Michele G; Altobelli I; Lioncino M; Perna A; Falco L; Palmiero G; Elliott PM; Limongelli G
    Circ Heart Fail; 2023 Aug; 16(8):e010687. PubMed ID: 37477018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.